Agrylin and Broken bone - a phase IV clinical study of FDA data

Summary:

Broken bone is reported as a side effect among people who take Agrylin (anagrelide hydrochloride), especially for people who are female, 50-59 old, also take Flexeril, and have Osteoporosis.

The phase IV clinical study analyzes which people have Broken bone when taking Agrylin. It is created by eHealthMe based on reports of 1,248 people who have side effects when taking Agrylin from the FDA, and is updated regularly.

What is Agrylin?

Agrylin has active ingredients of anagrelide hydrochloride. It is often used in primary thrombocythemia. eHealthMe is studying from 1,256 Agrylin users. Check the latest studies of Agrylin.

What is Broken bone?

Broken bone is found to be associated with 1,300 drugs and 1,494 conditions by eHealthMe. Check the latest studies of Broken bone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

1,248 people reported to have side effects when taking Agrylin.
Among them, 12 people (0.96%) have Broken bone.

Among these 12 people:

What is the gender of people who have Broken bone when taking Agrylin? *

female: 100 %
male: 0.0 %

What is the age of people who have Broken bone when taking Agrylin? *

What are other drugs people take besides Agrylin? *

What are other side effects people have besides Broken bone? *

Wound Infection Staphylococcal: 10 people, 83.33%
Foot Fracture: 10 people, 83.33%
Diarrhea: 10 people, 83.33%
Mouth Ulcers: 10 people, 83.33%
Dental Caries: 10 people, 83.33%
Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 10 people, 83.33%
Oedema Peripheral (superficial swelling): 10 people, 83.33%
Osteitis (a general term for inflammation of bone): 10 people, 83.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 10 people, 83.33%
Osteolysis (dissolution of bone): 10 people, 83.33%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 10 people, 83.33%
Osteoporosis (bones weak and more likely to break): 10 people, 83.33%
Thrombocytopenia (decrease of platelets in blood): 8 people, 66.67%
Essential Thrombocythaemia (chronic blood cancer): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Agrylin and have Broken bone?

- Check whether Broken bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Agrylin:

Agrylin (1,256 reports)

Broken bone treatments and more:

Broken bone (35,552 reports)

Browse all side effects of Agrylin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Broken bone:

Broken bone (1,300 drugs)

Browse all the conditions that are associated with Broken bone:

Broken bone (1,494 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on anagrelide hydrochloride (the active ingredients of Agrylin) and Agrylin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.